Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts safety review of Janus kinase inhibitors for inflammatory disorders 11 Febbraio 2022 News Human Referrals Initiation of DARWIN EU® Coordination Centre advances integration of real-world evidence into assessment of medicines in the EU 9 Febbraio 2022 News Human Data on medicines EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 Febbraio 2022 News Human COVID-19 Vaccines Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 Febbraio 2022 News Veterinary Antimicrobial resistance A stronger role for EMA 31 Gennaio 2022 News Corporate New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 Gennaio 2022 News Human Medicines COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 Gennaio 2022 News Human COVID-19 Medicines New EU rules for safe and high-quality medicines for animals become effective 28 Gennaio 2022 News Veterinary Regulatory and procedural guidance Medicines Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 Gennaio 2022 News Human Clinical trials Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 Gennaio 2022 News Human COVID-19 Vaccines 1 … 45 46 47 48 49 Page 49 of 379 50 51 52 53 … 379
EMA starts safety review of Janus kinase inhibitors for inflammatory disorders 11 Febbraio 2022 News Human Referrals
Initiation of DARWIN EU® Coordination Centre advances integration of real-world evidence into assessment of medicines in the EU 9 Febbraio 2022 News Human Data on medicines
EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 Febbraio 2022 News Human COVID-19 Vaccines
Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 Febbraio 2022 News Veterinary Antimicrobial resistance
New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 Gennaio 2022 News Human Medicines
COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 Gennaio 2022 News Human COVID-19 Medicines
New EU rules for safe and high-quality medicines for animals become effective 28 Gennaio 2022 News Veterinary Regulatory and procedural guidance Medicines
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 Gennaio 2022 News Human Clinical trials
Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 Gennaio 2022 News Human COVID-19 Vaccines